News 15.01.2025 January 14, 2025 - Zurich, Switzerland InSphero, the global leader in scalable and reliable 3D in vitro cell culture solutions for drug discovery, is proud to announce that Chief Scientific Officer, Dr. Madhu Nag, has been appointed as a member of the Society for Laboratory Automation and Screening (SLAS) Board of Directors, serving a three-year term starting...
News 13.01.2025 ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., and PARIS, Jan. 12, 2025 (GLOBE NEWSWIRE) -- Ad hoc announcement pursuant to Art. 53 LR – Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics, and Orano Med, a clinical-stage...
News 07.01.2025 Schlieren, Switzerland, January 7, 2025 – Kuros Biosciences USA Inc., (“Kuros”), a wholly owned subsidiary of Kuros Biosciences AG, a global leader in advanced musculoskeletal bone healing technologies, today announced a strategic five-year, exclusive sales agency agreement with Medtronic, a leading global healthcare technology company. The agreement provides Medtronic with...
News 02.01.2025 NovaGo Therapeutics AG, a clinical stage biotech company focused on advancing therapeutics for patients with spinal cord injury or diabetic retinopathy, today announced that its academic collaboration partners the Nogo-A Inhibition in Spinal Cord Injury Study Group (NISCI) published the results today for the investigation of NG101 in acute spinal...
News 21.12.2024 Schlieren (Zurich), December 19, 2024 – LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to LimmaTech’s multivalent toxoid vaccine candidate, LBT-SA7, designed to prevent skin and soft tissue...